Anticoagulants are commonly indicated in cirrhotic patients due to high rate of (pro)thrombotic conditions. Low molecular weight heparin (LMWH) is safe in patients with esophageal varices. However, the safety of LMWH is unknown in patients undergoing prophylactic endoscopic variceal ligation (EVL).
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients / Bianchini, Marcello; Cavani, Giulia; Bonaccorso, Ambra; Turco, Laura; Vizzutti, Francesco; Sartini, Alessandro; Gitto, Stefano; Merighi, Alberto; Banchelli, Federico; Villa, Erica; Schepis, Filippo. - In: LIVER INTERNATIONAL. - ISSN 1478-3223. - 38:7(2018), pp. 1253-1262. [10.1111/liv.13728]
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients
Bianchini, Marcello;CAVANI, GIULIA;TURCO, LAURA;Sartini, Alessandro;Villa, Erica;Schepis, Filippo
2018
Abstract
Anticoagulants are commonly indicated in cirrhotic patients due to high rate of (pro)thrombotic conditions. Low molecular weight heparin (LMWH) is safe in patients with esophageal varices. However, the safety of LMWH is unknown in patients undergoing prophylactic endoscopic variceal ligation (EVL).
| File | Dimensione | Formato | |
|---|---|---|---|
|
liv.13728(1).pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
622.92 kB
Formato
Adobe PDF
|
622.92 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
